Illustrative image – not actual.US-based drugmaker Abbott has launched drug eluting bioresorbable vascular scaffold (BVS) in India for the treatment of coronary artery disease (CAD).
Abbott's BVS is made of polylactide, a naturally dissolvable material that is commonly used in medical implants such as dissolving sutures. The launch of this BVS is supported by a clinical trial program.
Source: Business Stander
